Auditory Diagnostics and Error-based Treatment
- Conditions
- deafnesshearing loss10019243
- Registration Number
- NL-OMON51557
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 45
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
* Adult (over 18 years old at the time of inclusion)
* Post-lingually deafened (the subject had a good mastery of spoken language
before onset of deafness)
* Native Dutch speaker
* Implanted, either unilaterally or bilaterally, with a Cochlear Implant
manufactured by Cochlear Ltd (i.e., a Nucleus ® implant).
* Implanted with one of the following implants: CI422, CI512, CI522, CI532,
CI24R, CI24RE.
* Implanted for at least 12 months.
A potential subject for the CI user group who meets any of the following
criteria will be excluded from participation in this study:
* Known abnormally formed cochlea
* Known pre-implantation ossification of the cochlea
* Severe cognitive disorders affecting their ability to understand spoken
language
* Intense facial nerve stimulation
* Unaddressed electrode tip foldover
* More than 4 electrodes deactivated because of malfunction (open/short
circuit) or lack of response
* Additional illnesses or handicaps that could impact the ability to
participate in the study, at the clinician*s discretion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method